- Upper Research Office, The John Bull Building, Drake Circus
- +44 1752 583213
- claire.adams@plymouth.ac.uk

Profiles
Dr Claire Adams
Laboratory Manager
Peninsula Medical School (Faculty of Health: Medicine, Dentistry and Human Sciences)
Role
Laboratory Manager for the Biomedical Research laboratories at the Faculty of Medicine and Dentistry.
Qualifications
NEBOSH National General Certificate in Occupational Health and Safety
HCPC registered Clinical Scientist in Histocompatibility and Immunogenetics.PhD in Antibody Engineering (University of Bath).
BSc (Hons) Biological and Medicinal Chemistry (Exeter University).
Professional membership
Fellow of the Institute of Biomedical Science
British Association of Cancer Research (BACR)
UK Pharmacogenetics and Stratified Medicine Network
Research interests
Research expertise in Renal and Stem Cell Transplantation, Immunogenetics, Cancer research, Biomarkers
Immunology and Biobanking. At present, I work within Prof Oliver Hanemann's research group genotyping brain tumours to aid the develop of personalised medicine.
Key publications are highlighted
Journals
Articles
2017
'Cellular prion protein (PrPC) in the development of Merlin-deficient tumours'
Oncogene
, DOI
PEARL
2017
'Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target'
EBioMedicine
, DOI
PEARL
2015
'Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus'
Gastroenterology
148,
(2)
367-378
, DOI
PEARL
2013
'Serum neopterin as an indicator of increased risk of renal allograft rejection'
Transplant Immunology
28,
81-85
, DOI
2008
'The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection'
Clinical & Experimental Immunology
152,
(2)
239-244
, DOI
2004
'Differences in the kinetics, amplitude, and localization of ERK activation in anergy and priming revealed at the level of individual primary T cells by laser scanning cytometry'
J Immunol
, DOI
Conference Papers
2018
'High miR-9 levels represent a novel prognostic biomarker to predict development of malignant meningioma'
25th Biennial Congress of the European Association for Cancer Research (EACR25)
Amsterdam
30/06/2018
03/07/2018
PEARL